Literature DB >> 25359622

The effect of pulsed dye laser on high-risk basal cell carcinomas with response control by Mohs micrographic surgery.

Leticia Alonso-Castro1, Luis Ríos-Buceta, Pablo Boixeda, John Paoli, Carmen Moreno, Pedro Jaén.   

Abstract

Several reports have shown the effectiveness of pulsed dye laser (PDL) for the treatment of basal cell carcinoma (BCC). Most studies have focused on low-risk BCCs, but an important limitation has been the lack of histologic confirmation of the treatment results. The aim of this study was to assess the effectiveness of PDL in high-risk BCCs with complete histologic evaluation with Mohs micrographic surgery (MMS). Seven patients with high-risk BCCs located on the face were included. All tumors were treated with three sessions of PDL (595 nm) at 4-week intervals. The tumor and 4 mm of peripheral skin were treated with two stacked pulses with a 1-s delay, a fluence of 15 J/cm(2), a pulse duration of 2 ms, and a spot size of 7 mm. MMS was performed at least 1 month after the last PDL session including excisional tumor debulking prior to the first stage of MMS for standard histologic evaluation. Apparent complete clinical response was achieved in five of seven patients. MMS was finally performed in six patients, and clear margins were achieved after one stage of MMS. The histologic evaluation of the tumor debulking specimens showed complete clearance in four of six cases. One patient who did not undergo MMS showed a recurrence after 14 months. This is the first pilot study that demonstrates that PDL can be effective for the treatment of high-risk BCCs. Until further scientific evidence is available, treatment of high-risk BCCs should include histologic confirmation of clearance.

Entities:  

Mesh:

Year:  2014        PMID: 25359622     DOI: 10.1007/s10103-014-1686-1

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   3.161


  14 in total

1.  The National Comprehensive Cancer Network (NCCN) guidelines of care for nonmelanoma skin cancers.

Authors:  S J Miller
Journal:  Dermatol Surg       Date:  2000-03       Impact factor: 3.398

2.  CXC chemokine receptor CXCR4 expression enhances tumorigenesis and angiogenesis of basal cell carcinoma.

Authors:  G-S Chen; H-S Yu; C-C E Lan; K-C Chow; T-Y Lin; L-F Kok; M-P Lu; C-H Liu; M-T Wu
Journal:  Br J Dermatol       Date:  2006-05       Impact factor: 9.302

3.  Pulsed dye laser treatment of superficial basal cell carcinoma: realistic or not?

Authors:  K P Allison; M N Kiernan; R A Waters; R M Clement
Journal:  Lasers Med Sci       Date:  2003       Impact factor: 3.161

4.  595 nm pulsed dye laser for the treatment of superficial basal cell carcinoma.

Authors:  P Campolmi; L Mavilia; P Bonan; G Cannarozzo; T M Lotti
Journal:  Lasers Med Sci       Date:  2005-11-18       Impact factor: 3.161

5.  Real-time, in vivo confocal reflectance microscopy of basal cell carcinoma.

Authors:  Salvador González; Zeina Tannous
Journal:  J Am Acad Dermatol       Date:  2002-12       Impact factor: 11.527

6.  Pulsed dye laser as a novel non-surgical treatment for basal cell carcinomas: response and follow up 12-21 months after treatment.

Authors:  Nellie Konnikov; Mathew Avram; Abel Jarell; Zeina Tannous
Journal:  Lasers Surg Med       Date:  2011-02       Impact factor: 4.025

7.  Single treatment of non-melanoma skin cancers using a pulsed-dye laser with stacked pulses.

Authors:  Hien T Tran; Robert A Lee; Gagik Oganesyan; S Brian Jiang
Journal:  Lasers Surg Med       Date:  2012-04-17       Impact factor: 4.025

Review 8.  Nonmelanoma skin cancer of the head and neck I: histopathology and clinical behavior.

Authors:  John F McGuire; Norman N Ge; Senait Dyson
Journal:  Am J Otolaryngol       Date:  2008-07-22       Impact factor: 1.808

9.  The effect of 595 nm pulsed dye laser on superficial and nodular basal cell carcinomas.

Authors:  Sonali M Shah; Nellie Konnikov; Lyn M Duncan; Zeina S Tannous
Journal:  Lasers Surg Med       Date:  2009-08       Impact factor: 4.025

10.  Combined 585 nm pulsed-dye and 1,064 nm Nd:YAG lasers for the treatment of basal cell carcinoma.

Authors:  H Ray Jalian; Mathew M Avram; Kelly J Stankiewicz; Joshua D Shofner; Zeina Tannous
Journal:  Lasers Surg Med       Date:  2013-11-23       Impact factor: 4.025

View more
  1 in total

Review 1.  [Laser treatment of basal cell carcinoma].

Authors:  C Salavastru; G S Tiplica; K Fritz
Journal:  Hautarzt       Date:  2018-01       Impact factor: 0.751

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.